Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The clinical efficacy of unilateral biportal endoscopy contralateral inclinatory approach in the treatment of lumbar foraminal stenosis].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2026
Same author

[Nasal infection with Mycobacterium avium complex: a case report].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

Effect of stump-preserving arthroscopic reconstruction or stump-eliminating arthroscopic reconstruction combined with exercise rehabilitation therapy on knee functional recovery in patients with anterior cruciate ligament injuries.

Annals of the Royal College of Surgeons of England·2025
Same author

[A case of thoracic aortic aneurysm after coronary artery bypass grafting was treated with integrative branch stent combined with extracorporeal fenestration technique and internal branch technique].

Zhonghua xin xue guan bing za zhi·2025
Same author

Quantum Electrodynamics in Strong Electromagnetic Fields: Substate Resolved Kα Transition Energies in Heliumlike Uranium.

Physical review letters·2025
Same author

Association of treatment methods and survival in esophageal neuroendocrine carcinoma population of Surveillance, Epidemiology, and End Results database: a retrospective cohort study.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2025
Same journal

Therapeutic evaluation of myricetin in experimental arthritis: modulation of inflammatory signaling and oxidative stress pathways.

Inflammopharmacology·2026
Same journal

Cortistatin as a pleiotropic regulator of neuroimmune and inflammatory pathways in experimental disease: a scoping review of preclinical evidence.

Inflammopharmacology·2026
Same journal

Clemastine ameliorates ulcerative colitis-induced cognitive impairment by restoring PI3K/Akt/GSK-3β signaling and suppressing ferroptosis.

Inflammopharmacology·2026
Same journal

Preclinical investigation of hydroxychloroquine loaded ethosomal gel for topical treatment of rheumatoid arthritis.

Inflammopharmacology·2026
Same journal

Antioxidative and anti-inflammatory effects of monoterpene linalool in rats with letrozole-induced polycystic ovarian syndrome: modulation of autophagy and apoptosis.

Inflammopharmacology·2026
Same journal

Bioactive compounds of Glycyrrhiza glabra and their functional role in modulating gut inflammation and intestinal homeostasis.

Inflammopharmacology·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Acamprosate modulates experimental autoimmune encephalomyelitis.

Z Sternberg1, A Cesario, K Rittenhouse-Olson

  • 1Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High Street, Buffalo, NY 14203, USA. zs2@buffalo.edu

Inflammopharmacology
|November 18, 2011
PubMed
Summary
This summary is machine-generated.

Acamprosate significantly reduced neurological deficits in an animal model of multiple sclerosis (MS). The 100 mg/kg dose showed the most promise, decreasing lesions and central nervous system demyelination.

More Related Videos

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Related Experiment Videos

Last Updated: May 27, 2026

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Area of Science:

  • Neuroimmunology
  • Experimental autoimmune encephalomyelitis (EAE) research
  • Multiple sclerosis (MS) animal models

Background:

  • Taurine, an amino acid, exhibits immunomodulatory and neuromodulatory properties.
  • Acamprosate, a synthetic taurine derivative, readily crosses the blood-brain barrier.
  • Acamprosate is used to treat alcohol withdrawal by modulating neurotransmitter systems.

Purpose of the Study:

  • To evaluate acamprosate's efficacy in reducing pathological features of EAE.
  • To investigate acamprosate's therapeutic potential in an MS animal model.

Main Methods:

  • EAE induced in C57BL/6 female mice using myelin oligodendrocyte glycoprotein (MOG) amino acid 35-55.
  • Mice treated with acamprosate at doses of 20, 100, and 500 mg/kg for 21 days.

Main Results:

  • Neurological scores at peak disease were reduced by 21% (20 mg/kg), 64% (100 mg/kg), and 9% (500 mg/kg).
  • The 100 mg/kg group showed reduced inflammatory lesions and central nervous system (CNS) demyelination.
  • Tumor necrosis factor-alpha (TNF-α) levels in blood were significantly reduced in the 500 mg/kg group.

Conclusions:

  • Acamprosate demonstrates potential as a therapeutic agent for MS.
  • Taurine analogs warrant further investigation for MS treatment strategies.